Does Rallies show Form 4 insider transactions for BDX?

Yes. Rallies tracks BDX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BDX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BDX. It does not provide personalized investment advice.

BDX (Becton, Dickinson and Co.) Stock Analysis - Insider Trades

Becton, Dickinson and Co. (BDX) is a publicly traded Healthcare sector company. As of May 20, 2026, BDX trades at $147.16 with a market cap of $39.22B and a P/E ratio of 37.18. BDX moved +0.07% today. Year to date, BDX is -26.14%; over the trailing twelve months it is -16.82%. Its 52-week range spans $141.82 to $251.99. Analyst consensus is buy with an average price target of $182.20. Rallies surfaces BDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BDX stock inside the company?

Recent BDX insider activity includes Feld Michael sold 74, Feld Michael sold 75, Feld Michael sold 75, SCOTT BERTRAM L sold 953, and Feld Michael sold 75. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BDX Key Metrics

Key financial metrics for BDX
Metric	Value
Price	$147.16
Market Cap	$39.22B
P/E Ratio	37.18
EPS	$3.95
Dividend Yield	1.05%
52-Week High	$251.99
52-Week Low	$141.82
Volume	2.06M
Avg Volume	0
Revenue (TTM)	$21.37B
Net Income	$1.14B
Gross Margin	46.79%

Recent BDX Insider Trades

Feld Michael sold 74 (~$11.24K) on Apr 27, 2026.
Feld Michael sold 75 (~$11.76K) on Mar 26, 2026.
Feld Michael sold 75 (~$13.64K) on Feb 26, 2026.
SCOTT BERTRAM L sold 953 (~$174.03K) on Feb 18, 2026.
Feld Michael sold 75 (~$15.20K) on Jan 26, 2026.

Latest BDX News

BDX jumps after Q2 results, raised FY26 adjusted EPS guidance, new CFO named — May 7, 2026
Becton Dickinson to Deploy AI-Powered Pyxis Pro and Alaris Systems at Wellstar — May 5, 2026
Becton Dickinson Earns 2026 Best Employers Health Award, Cigna Gold Workforce Designation — Apr 30, 2026
BDX slides 3% ahead of April 30 earnings as Alaris overhang returns — Apr 29, 2026
Becton Dickinson Launches CentroVena One™ System Cutting Steps by 30% — Apr 29, 2026

BDX Analyst Consensus

10 analysts cover BDX: 0 strong buy, 5 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $182.20.

Common questions about BDX

Who is trading BDX stock inside the company?: Recent BDX insider activity includes Feld Michael sold 74, Feld Michael sold 75, Feld Michael sold 75, SCOTT BERTRAM L sold 953, and Feld Michael sold 75. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BDX?: Yes. Rallies tracks BDX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BDX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BDX. It does not provide personalized investment advice.